ingenimed1

Ingenimed

Improving new lives with affordable and suitable technology.

Social Challenge

Approximately 50% of newborns have some incidence of Neonatal Jaundice and between 4% and 6% develop Pathological Jaundice. In 2013 approximately 41,000 children required phototherapy treatment. If not treated properly, jaundice can cause permanent neurological problems. The technology available for treatment in rural areas is inadequate.

Social Enterprise

Ingenimed designs, produces and sells blue light phototherapy equipment called “NEOLED”, a high-quality, cost-effective treatment for neonatal jaundice. It offers two solutions: a conventional one used directly over incubators and an alternative known as “Madre Canguro” or Kangaroo Pouch.

Impact Statistics
  • 2,800 newborns have benefitted from the technology
  • 400% increase in beneficiaries in 2013
  • US$ 78,765 NESsT investment to date

Learn More

To reach this portfolio organization directly, please visit:
www.ingenimed.net

How can you help?

If you would like to learn more, please contact:

peru@nesst.org